Bicycle Therapeutics' Series A - II Round

Bicycle Therapeutics raised a round of funding on October 14, 2014.

Bicycle Therapeutics has developed a proprietary bicyclic peptide based technology that enables the discovery of a new class of drug candidates ('bicycles') providing antibody-like affinity and select…

Articles about Bicycle Therapeutics' Series A - II Round: